Glioma Molecular Markers and Pathology Reports: What Every Patient Should Know
Glioma molecular markers can change the final diagnosis, CNS WHO grade, prognosis and treatment pathway. This patient-focused guide explains how to read IDH, 1p/19q, MGMT, ATRX, TP53, CDKN2A/B, TERT, EGFR, H3 and DNA-methylation results, when to seek a second opinion, and how individualized Ayurvedic support can be coordinated with complete neuro-oncology care.